Provided by Tiger Trade Technology Pte. Ltd.

Eterna Therapeutics Inc.

3.91
-0.1700-4.17%
Pre-market: 4.200.2921+7.47%05:28 EDT
Volume:22.54K
Turnover:89.06K
Market Cap:6.38M
PE:-0.21
High:4.16
Open:4.01
Low:3.84
Close:4.08
52wk High:71.50
52wk Low:3.18
Shares:1.63M
Float Shares:1.20M
Volume Ratio:0.18
T/O Rate:1.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-18.6059
EPS(LYR):-55.8903
ROE:-320.72%
ROA:-105.57%
PB:2.00
PE(LYR):-0.07

Loading ...

Company Profile

Company Name:
Eterna Therapeutics Inc.
Exchange:
NASDAQ
Establishment Date:
2018
Employees:
6
Office Location:
1035 Cambridge Street,Suite 18A,Cambridge,Massachusetts,United States
Zip Code:
02141
Fax:
- -
Introduction:
Eterna Therapeutics Inc., a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system. The company has a license agreement with Factor Bioscience Limited. Eterna Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Directors

Name
Position
Robert J. Spiegel
Director

Shareholders

Name
Position